1 / 26

Cytotoxicity

Cytotoxicity. Mitzi Nagarkatti Professor, Dept. Microbiology and Immunology Massey Cancer Center 533 Medical Sciences Building Tel. # 827-1555. Ag. Ab. C’. Cytotoxicity = Cell killing or lysis. Effectors Complement (C’) Macrophages (M f ) Granulocyte Natural Killer (NK) cells

arleen
Télécharger la présentation

Cytotoxicity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cytotoxicity Mitzi Nagarkatti Professor, Dept. Microbiology and Immunology Massey Cancer Center 533 Medical Sciences Building Tel. # 827-1555

  2. Ag Ab C’ Cytotoxicity = Cell killing or lysis Effectors • Complement (C’) • Macrophages (Mf) • Granulocyte • Natural Killer (NK) cells • Cytotoxic T lymphocytes (CTL)

  3. Target Cells • Tumors • Virally infected cells • Cells infected with intracellular bacteria

  4. Macrophage • Monocyte - blood • Alveolar Mfs–lung • Histiocytes – connective tissue • Kupffer cells – liver • Mesangial cells – kidney • Microglial cells – brain

  5. Function of macrophages • Phagocytosis • Antigen Processing and Presentation • Cytotoxicity • Direct Cytotoxicity • Antibody dependent cell-mediated cytotoxicity (ADCC) Ag Target Mf Ab Fc receptor

  6. Target Target Mf Mf • Normal Mfs are not lytic • Activated Mfs are lytic Activation mediated by Th1 2 signals required: Cytokine - Interferon-g (IFN-g) CD40L

  7. Mechanisms of Macrophage-mediated cytotoxicity • Reactive oxygen intermediates (ROIs): O2-, OH-, H2O2 • Reactive nitrogen intermediates (RNIs): NO, NO2 • Tumor necrosis factor-a • Lysosomal enzymes

  8. Activation of Cytotoxic T lymphocytes IL-2 IL-2R CTL Precursor Ag Activated CTL MHC Cl. I CD8 Target TCR Ag Proliferation, Differentiation Activation

  9. CTL Activation • Ag + Class I MHC on infected cells/grafts CTL • Ag + Dendritic cells (Class I) – cross priming of naïve CD8+ cells • Ag + APC + CD4+ Th CTL

  10. Characteristics of Effector CTL • Increased adhesion molecule expression (LFA-1, CD2, CD44, CD45RO) • Decreased expression of L-selectin (prevents homing to lymph nodes) • Expression of VLA-4 (Very Late Ag-4) which interacts with VCAM-1 (vascular cell adhesion molecule) on endothelial cells leading to inflammation • Production of effector lytic molecules

  11. Mechanism of CTL-mediated killing of targets Pathways • FasL • Perforin/Granzyme • Cytokines: IFN-g, TNF-a and TNF-b Perforin TCR Ag CTL MHC Granzyme Fas FasL Perforin

  12. Immunologic Synapse between CTL and target cell Supramolecular Activation Cluster (SMAC) cSMAC (central) MHCp:TCR CD28:CD80/CD86 Exocytic vesicles pSMAC (Peripheral) LFA-1:ICAM-1 Microtubules Outside of SMAC CD43/CD45

  13. Natural Killer Cells • Innate immunity • Large granular lymphocytes • Kill virus infected cells and tumor cells • Lysis non-MHC restricted • CD3-, TCR-, Ig- • Present in SCID (severe combined immunodeficiency disease) mice • Asialo GM1+, NK1.1+ • Intermediate affinity IL-2R+ • FcR(CD16)+, Mediate ADCC

  14. ITIM ITIM Natural Cytotoxicity Receptors Altered-self Hypothesis • Activating Receptor: Contain immunoreceptor tyrosine-based activation motif (ITAM) • Inhibitory Receptor: Contain Immunoreceptor tyrosine-based inhibitory motif (ITIM) ITAM

  15. NK Cell Receptor • KLR (Killer cell lectin-like receptor): CD94, NKG2 • KIR (Killer cell Ig-like receptor): Ly49 Human: NKG2A and B are inhibitory NKG2C and D are activating Mouse: Ly49H is activating Other Ly49 is inhibitory Recognize: Nonclassical MHC: HLA-E – human; Qa-1 – mouse (Classical MHC : HLA-A,B,C,D –human H-2K,I,D – mouse

  16. Beneficial and Deleterious Effects of Cytotoxicity • Protection against • Tumors • Virus-infected cells • Intracellular bacteria • Parasites • Fungal infections • Cause • Autoimmune disorders • Transplant rejection • Immunopathology

  17. Apoptosis (Programmed cell death) Nuclear and cytoplasmic condensation Membrane blebs DNA fragmentation (early, 180bp multiples) Apoptotic bodies Phagocytosis Localizes infection Ex. Development 3H-thymidine-release assay Necrosis (Pathologic cell death) Cell Swelling and lysis Inflammation DNA fragmentation (late, varying size) Spreads infection Ex. Stress 51Cr-release assay Cell Death

  18. Role of Apoptosis • Embryogenesis • Organogenesis • Cytotoxic Lymphocyte killing of targets • FasL • Perforin/Granzyme TCR Ag CTL MHC Granzyme Fas FasL Perforin

  19. Activation induced cell death (AICD) • In the Periphery Ag + Ag IL-2 Memory Resting T Cell - Ag Activated T Cell Cycling T Cell

  20. Mature T cells Thymus Bone Marrow T Cell Development Spleen, LN, Peripheral blood Thymus – Central Tolerance • Death by Neglect • Positive Selection: T cells with low affinity for self MHC • Negative Selection: Deletion of autoreactive T cells

  21. Caspase 9 Procaspase 8 Caspase 8 Procaspase 3 Receptor mediated Pathway Mitochondrial Pathway Apoptosis Signaling Bcl-2 Apaf-1 FasL (CD95L) Cytochrome c Fas (CD95) Procaspase 9 FADD (Fas associated death domain) Caspase 3 Activates DNase, Inactivate DNA repair enzymes DNA fragmentation

  22. Molecules involved in apoptosis • Tumor necrosis factor receptor (TNFR) superfamily: Fas (CD95) TNFR (I and II) Ligands: Induce apoptosis FasL (CD96L) TNF – a and b (LymphotoxinLT a+b) TRAIL (TNF-related apoptosis inducing ligand) • Bcl-2 family Bcl-2, Bcl-xL –Inhibit apoptosis Bax, Bad – Pro-apoptotic

  23. Apoptosis and Disease Lack of apoptosis • Cancer • Autoimmunity: • Mouse • Lpr – CD95 deficient • Gld – CD95 Ligand defective • Lprcg – CD95 intracellular death domain defect • Human • Type Ia Autoimmune lymphoproliferative disease (ALPS) – CD95 defect • Type Ib ALPS – CD95L defect • Type II ALPS – CD95 signaling defect

  24. Induction of apoptosis • AIDS and other viral infections • Neurodegenerative disorder

  25. Suggested Reading • Immunobiology: The Immune System in Health and Disease by Janeway et al. 6th ed., 2005. Pg 89-95; 341-361;717.

  26. Exam Format • Multiple Choice • Essays • Both

More Related